Predictive factors of responses to the treatment of chronic hepatitis type B with recombinent interferon
✍ Scribed by Porres, JC; Ruiz-Moreno, M; Ibarra, Mz; Bartolomé, J; Moreno, A; Carreńo, V
- Book ID
- 122416912
- Publisher
- Elsevier Science
- Year
- 1990
- Tongue
- English
- Weight
- 69 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The response marker for interferon has not been investigated fully for hepatitis B viruses (HBVs) in the Philippines where novel subtypes B5 and C5 were recognized recently. The prediction parameters for interferon treatment were assessed, with emphasis on the mutation patterns in the b
Recombinant human a-interferon is now under intensive investigation as therapy for chronic Type B hepatitis. Recent reports have suggested that prolonged a- interferon therapy may induce autoimmune reactions. We have evaluated the problem of autoimmunity related to a-interferon therapy by testing fo